Skip to content

IMMOMED

Active Public limited companyfounded 1993active for 32 yearsMezenlaan 3, 8430 MiddelkerkeKBO/BCE: BE 0451.808.974

Lifetime

20 annual accounts with figures on one time axis, 31 filings since 1995
peak of €70,098 in 2015
-€644▼ €862
lowest -€30,072 in 2018
-€7,757▼ €511
peak of €256,423 in 2016
€132,374▼ 5.5%
€16,155▲ 3.0%
Board6 names since 1993
2 directors and 1 other
Documentsfilings and deeds
02-10-2026121 days before the deadline
2026micro format
Gross margin from €218 to -€644Loss of €7,757

Key points

from the 2026 annual accounts

Equity

€132,374 from €256,423 in 2016

Equity fell by 48% in 10 years.

Losses

-€124,049 in ten years
2017-30,07220182019202020212022202320242025-7,7572026

Every financial year from 2017 to 2026 closed with a loss. 2018 was the heaviest.

Filings

31 annual accounts since 1995
deadline200020102020

The 2019 accounts came 7 days late. The other nine of the last ten were filed on time.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 12,344 companies had the same profile as IMMOMED has now. Each dot stands for 31 companies, two years later.

90.1%
were still trading
8.7%
stopped another way
0.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 12,344 companies, not a prediction for IMMOMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Daily manager
Director, since 06-12-2023
Director, since 06-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0451808974
2 directors appointed, 2 resignations, 2 reappointments changes role from director to day-to-day manager · and resign · and reappointed · Board meeting of 06-12-2023 · Gazette deed
3 directors reappointed , and · General meeting of 30-11-2022 · Gazette deed
3 directors reappointed , and · General meeting of 30-11-2016 · Gazette deed
All 49 events

Official details

Source: KBO
Status
Active since 17-12-1993Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 2110001and 2 others3 activities on the establishment unitFrom the articles
Establishment unit
2.065.994.6848430 Middelkerke, since 21-03-1994
Financial year end
30 June
Peppol
Reachable since 19-09-2025
Company details

Annual accounts to 30-06-2026

€148,529▼ 4.7%
Filing
Filed on 02-10-2026, 121 days before the end of the filing period
Financials

Insights on IMMOMED

IMMOMED files the micro format. That format states no turnover. The gross margin fell from €4,510 in 2007 to -€644 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IMMOMED

What is the company number of IMMOMED?
The company number of IMMOMED is 0451.808.974. The VAT number is the same number with BE in front: BE 0451.808.974.
Where is IMMOMED based?
The registered office is at Mezenlaan 3, 8430 Middelkerke.Company details
What does IMMOMED do?
According to the KBO register, the main activity of the establishment unit is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 2110001). The KBO lists 2 more.
What is the legal form of IMMOMED?
IMMOMED is a public limited company (NV).
When was IMMOMED founded?
IMMOMED was founded on 17-12-1993.
Is IMMOMED still active?
Yes, IMMOMED is an active enterprise in the KBO register.
What is the turnover of IMMOMED?
The annual accounts for financial year 2026 state no turnover. The micro format does not require it.Financials
Is IMMOMED profitable?
In financial year 2026, IMMOMED made a loss of €7,757.
Where can I find the annual accounts of IMMOMED?
IMMOMED filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of IMMOMED due?
IMMOMED must file the annual accounts for financial year 2027 by 31-01-2028.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.